ARTICLE | Company News
Innovate Oncology, Prostagenics LLC deal
April 25, 2005 7:00 AM UTC
IOVO acquired an exclusive worldwide license to develop and commercialize Prostagenics’ Capridine-Beta for cancer. IOVO is preparing an IND for a Phase I trial of the nitroacridine derivative in prost...